Mark Nellist

10.3k total citations
72 papers, 3.3k citations indexed

About

Mark Nellist is a scholar working on Physiology, Molecular Biology and Oncology. According to data from OpenAlex, Mark Nellist has authored 72 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Physiology, 28 papers in Molecular Biology and 23 papers in Oncology. Recurrent topics in Mark Nellist's work include Tuberous Sclerosis Complex Research (57 papers), Polyomavirus and related diseases (21 papers) and Histiocytic Disorders and Treatments (20 papers). Mark Nellist is often cited by papers focused on Tuberous Sclerosis Complex Research (57 papers), Polyomavirus and related diseases (21 papers) and Histiocytic Disorders and Treatments (20 papers). Mark Nellist collaborates with scholars based in Netherlands, United States and United Kingdom. Mark Nellist's co-authors include Dicky Halley, Miriam Goedbloed, Ans van den Ouweland, Floor E. Jansen, Ans M.W. van den Ouweland, Marianne Hoogeveen‐Westerveld, Bernard A. Zonnenberg, Eleonora Aronica, Magitha M. Maheshwar and Senno Verhoef and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Molecular Cell.

In The Last Decade

Mark Nellist

70 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Nellist Netherlands 31 2.1k 1.4k 871 770 303 72 3.3k
Dicky Halley Netherlands 36 2.0k 1.0× 1.8k 1.3× 678 0.8× 1.6k 2.1× 714 2.4× 129 5.2k
Hiroaki Onda United States 22 1.3k 0.6× 2.2k 1.6× 581 0.7× 423 0.5× 252 0.8× 36 3.4k
Sandra L. Dabora United States 18 1.6k 0.7× 1.2k 0.9× 695 0.8× 317 0.4× 541 1.8× 28 2.7k
Jeffrey E. DeClue United States 29 878 0.4× 1.6k 1.1× 528 0.6× 315 0.4× 381 1.3× 43 2.9k
Jeremy P. Cheadle United Kingdom 35 1.4k 0.7× 3.1k 2.2× 2.3k 2.7× 1.2k 1.6× 681 2.2× 76 6.5k
Benjamin B. Roa United States 29 311 0.2× 1.9k 1.4× 795 0.9× 1.8k 2.3× 126 0.4× 65 4.3k
John R.W. Yates United Kingdom 19 522 0.3× 802 0.6× 204 0.2× 490 0.6× 135 0.4× 30 1.7k
Tatyana V. Taksir United States 17 441 0.2× 1.0k 0.7× 336 0.4× 242 0.3× 90 0.3× 24 1.9k
Mary Pat Reeve United States 8 907 0.4× 859 0.6× 337 0.4× 610 0.8× 154 0.5× 17 1.8k
Lieve Umans Belgium 28 598 0.3× 1.9k 1.3× 350 0.4× 259 0.3× 138 0.5× 49 2.8k

Countries citing papers authored by Mark Nellist

Since Specialization
Citations

This map shows the geographic impact of Mark Nellist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Nellist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Nellist more than expected).

Fields of papers citing papers by Mark Nellist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Nellist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Nellist. The network helps show where Mark Nellist may publish in the future.

Co-authorship network of co-authors of Mark Nellist

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Nellist. A scholar is included among the top collaborators of Mark Nellist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Nellist. Mark Nellist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cappellano, Andréa Maria, Thiago Gerônimo Pires Alegria, Mark Nellist, et al.. (2024). Molecular and Functional Assessment of TSC1 and TSC2 in Individuals with Tuberous Sclerosis Complex. Genes. 15(11). 1432–1432. 1 indexed citations
2.
Douben, Hannie, Marianne Hoogeveen‐Westerveld, Mark Nellist, et al.. (2023). Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome. Human Mutation. 2023. 1–14. 2 indexed citations
3.
Besterman, Aaron D., Thorsten Althoff, Peter Elfferich, et al.. (2021). Functional and structural analyses of novel Smith-Kingsmore Syndrome-Associated MTOR variants reveal potential new mechanisms and predictors of pathogenicity. PLoS Genetics. 17(7). e1009651–e1009651. 9 indexed citations
4.
Brohée, Laura, Claudia Antoni, Stephan Kiontke, et al.. (2021). TSC1 binding to lysosomal PIPs is required for TSC complex translocation and mTORC1 regulation. Molecular Cell. 81(13). 2705–2721.e8. 39 indexed citations
5.
Farach, Laura S., William T. Gibson, Steven Sparagana, et al.. (2017). TSC2 c.1864C>T variant associated with mild cases of tuberous sclerosis complex. American Journal of Medical Genetics Part A. 173(3). 771–775. 11 indexed citations
6.
García-Aguilar, Ana, Carlos Guillén, Mark Nellist, Alberto Bartolomé, & Manuel Benito. (2016). TSC2 N-terminal lysine acetylation status affects to its stability modulating mTORC1 signaling and autophagy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1863(11). 2658–2667. 32 indexed citations
7.
Nellist, Mark, Rutger W. W. Brouwer, Christel Kockx, et al.. (2015). Targeted Next Generation Sequencing reveals previously unidentified TSC1 and TSC2 mutations. BMC Medical Genetics. 16(1). 10–10. 58 indexed citations
8.
Hoogeveen‐Westerveld, Marianne, Rosemary Ekong, Sue Povey, et al.. (2011). Functional assessment of TSC1 missense variants identified in individuals with tuberous sclerosis complex. Human Mutation. 33(3). 476–479. 34 indexed citations
9.
Hoogeveen‐Westerveld, Marianne, et al.. (2010). Analysis of TSC1 truncations defines regions involved in TSC1 stability, aggregation and interaction. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(9). 774–781. 21 indexed citations
10.
Majores, Michael, Jana Fassunke, Katharina Pernhorst, et al.. (2009). Hamartin Variants That Are Frequent in Focal Dysplasias and Cortical Tubers Have Reduced Tuberin Binding and Aberrant Subcellular Distribution In Vitro. Journal of Neuropathology & Experimental Neurology. 68(10). 1136–1146. 10 indexed citations
11.
Boer, Karin, Dirk Troost, Wendy Timmermans, et al.. (2008). Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Neuroscience. 156(1). 203–215. 46 indexed citations
12.
Nellist, Mark, Őzgür Sancak, Miriam Goedbloed, et al.. (2008). Functional characterisation of the TSC1–TSC2 complex to assess multiple TSC2 variants identified in single families affected by tuberous sclerosis complex. BMC Medical Genetics. 9(1). 10–10. 16 indexed citations
13.
Jansen, Floor E., Olga Braams, Koen L. Vincken, et al.. (2007). Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations. Neurology. 70(12). 908–915. 73 indexed citations
14.
Jansen, Floor E., Koen L. Vincken, Ale Algra, et al.. (2007). Cognitive impairment in tuberous sclerosis complex is a multifactorial condition. Neurology. 70(12). 916–923. 155 indexed citations
15.
Nellist, Mark, Őzgür Sancak, Miriam Goedbloed, et al.. (2005). Large Deletion at the TSC1 Locus in a Family with Tuberous Sclerosis Complex. Genetic Testing. 9(3). 226–230. 8 indexed citations
16.
Jansen, Anna, Őzgür Sancak, Daniela D’Agostino, et al.. (2005). Mild Epilepsy Phenotype in TSC2 Patients with Codon 905 Mutations. Epilepsia. 46. 52–52. 2 indexed citations
17.
Nellist, Mark, Peter C. Burgers, Ans M.W. van den Ouweland, Dicky Halley, & Theo M. Luider. (2005). Phosphorylation and binding partner analysis of the TSC1–TSC2 complex. Biochemical and Biophysical Research Communications. 333(3). 818–826. 29 indexed citations
18.
Nellist, Mark, Őzgür Sancak, Miriam Goedbloed, et al.. (2004). Distinct effects of single amino-acid changes to tuberin on the function of the tuberin–hamartin complex. European Journal of Human Genetics. 13(1). 59–68. 65 indexed citations
19.
Maheshwar, Magitha M., Richard Sandford, Mark Nellist, et al.. (1996). Comparative Analysis and Genomic Structure of the Tuberous Sclerosis 2 (TSC2) Gene in Human and Pufferfish. Human Molecular Genetics. 5(1). 131–137. 56 indexed citations
20.
Peral, Belén, Christopher J. Ward, Peter Thompson, et al.. (1994). Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease — a contiguous gene syndrome. Nature Genetics. 8(4). 328–332. 355 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026